| Print
Bristol-Myers Squibb Co (BMY)
Common StockOpen
$63.275
Previous close
$62.86
Trade high
$64.13
Volume
15,525,465
Year high
$68.64
Year low
$42.52
Dividend yield
3.99%
Market capitalisation
$127.47 bn
P/E ratio
13.85
ISIN
US1101221083
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 02/07/2026 | 02/10/2026 |
| Ex-dividend date | 02/07/2026 | 02/10/2026 |
| Payment date | 03/08/2026 | 02/11/2026 |
| Amount | $0.63 | $0.63 |
Company profile
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.